Growth Metrics

Cross Country Healthcare (CCRN) Return on Sales (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Return on Sales for 16 consecutive years, with 146.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 14601.0% year-over-year to 146.0%, compared with a TTM value of 0.12% through Dec 2025, down 11.0%, and an annual FY2025 reading of 42.8%, up 4281.0% over the prior year.
  • Return on Sales was 146.0% for Q4 2025 at Cross Country Healthcare, up from 0.02% in the prior quarter.
  • Across five years, Return on Sales topped out at 146.0% in Q4 2025 and bottomed at 0.05% in Q2 2024.
  • Average Return on Sales over 5 years is 7.33%, with a median of 0.04% recorded in 2021.
  • The sharpest move saw Return on Sales fell -9bps in 2024, then skyrocketed 14601bps in 2025.
  • Year by year, Return on Sales stood at 0.12% in 2021, then crashed by -52bps to 0.06% in 2022, then tumbled by -62bps to 0.02% in 2023, then plummeted by -155bps to 0.01% in 2024, then skyrocketed by 1205850bps to 146.0% in 2025.
  • Business Quant data shows Return on Sales for CCRN at 146.0% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q2 2025.